Baxter recalls certain lots of two IV solutions
Baxter International Inc. recently recalled certain lots of two intravenous solutions distributed to U.S. customers and distributors between June 6 and Dec. 16, which may contain particulate matter, the Food and Drug Administration reports. The company directed customers not to use product from the two recalled lots, which may be returned for credit. Any associated adverse reactions or quality problems may be reported to the FDA’s MedWatch program.
Related News Articles
Headline
The National Collaborative for Improving the Clinical Learning Environment this week released guidance to help health care system leaders work with clinical…
Headline
The Centers for Medicare & Medicaid Services should continue to work with national standards body X12 to include the new unique device identifier on its…
Headline
The Centers for Disease Control and Prevention today issued recommendations to help health care providers and laboratories prevent the spread of Candida auris…
Headline
The AHA today urged the Centers for Medicare & Medicaid Services not to finalize in the calendar year 2018 final rule its proposal to redesign the home…
Headline
Inpatient rehabilitation facilities and long-term care hospitals have until Sept. 30 to review their 2016 quality data before it is publicly reported on the…
Headline
The Institute for Safe Medication Practices yesterday released a tool to help hospitals and outpatient facilities evaluate their safety practices for “…